title: Antilymphoblast globulin treatment of steroid-resistant rejection in cyclosporine-immunosuppressed renal transplant recipients.
authors.affiliation: Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY 10467.
authors.forename: V A
authors.initials: VA
authors.lastname: Tellis
authors.forename: A J
authors.initials: AJ
authors.lastname: Matas
authors.forename: T A
authors.initials: TA
authors.lastname: Quinn
authors.forename: D
authors.initials: D
authors.lastname: Glicklich
authors.forename: R J
authors.initials: RJ
authors.lastname: Weiss
authors.forename: R J
authors.initials: RJ
authors.lastname: Soberman
authors.forename: F J
authors.initials: FJ
authors.lastname: Veith
mesh_terms: D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D003524:Cyclosporins / Q000627:therapeutic use*; D004351:Drug Resistance; D005260:Female; D006084:Graft Rejection / Q000276:immunology*; D006085:Graft Survival; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D013256:Steroids / Q000627:therapeutic use
chemical_list: D000961:Antilymphocyte Serum; D003524:Cyclosporins; D013256:Steroids